HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness | MicrobiomeTrials← Back to trialsNCT07369622
HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-01-20Est. Completion: 2027-06-20
Enrollment target: 228 participants Other microbiome trials you might be interested in
Gout Initiating Urate-loweringUrate-lowering Therapy
The goal of this clinical trial is to: compare a new digital self-management treatment strategy to usual care, for patie…
Oslo, NorwayCompleted Mar 2028
Health LiteracyGout ArthritisGout Initiating Urate-loweringUrate-lowering TherapyTelehealthDigital HealthAdherence
The aim of this clinical trial is to evaluate whether nurse-led telehealth support helps individuals with gout better ma…
Aarhus, DenmarkEst. completion Aug 1, 2027